Risperidone side effects

被引:0
作者
Conley, RR [1 ]
机构
[1] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Dept Psychiat, Baltimore, MD 21228 USA
关键词
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The overall effectiveness of traditional antipsychotics has been hindered by their extrapyramidal side effects, which contribute to noncompliance and relapse in patients with schizophrenia. The side effects associated with traditional antipsychotic treatment are generally minimal in patients who take risperidone, a combined 5-HT2/D-2 antagonist, but the literature is sparse on adverse events among the newer atypical antipsychotics. Risperidone is associated with relatively few motor side effects compared with the traditional antipsychotics, and weight gain is less likely with risperidone than with either clozapine or olanzapine. While increased prolactin levels have been reported in patients taking risperidone, little correlation has been found between prolactin levels and adverse events. As antipsychotic treatment options expand to include the new agents, it is important for clinicians to anticipate side effects and to query patients about specific adverse events.
引用
收藏
页码:20 / 23
页数:4
相关论文
共 28 条
  • [1] ALLISON DB, 1998, ANN M AM PSYCH ASS J, P202
  • [2] Olanzapine versus placebo and haloperidol - Acute phase results of the North American double-blind olanzapine trial
    Beasley, CM
    Tollefson, G
    Tran, P
    Satterlee, W
    Sanger, T
    Hamilton, S
    Fabre, L
    Small, J
    Ereshefsky, L
    True, J
    Nemeroff, C
    Risch, SC
    Perry, PJ
    Potkin, SG
    Borison, RL
    James, S
    Meltzer, HY
    Iqbal, N
    Fann, WE
    Gewirtz, GR
    Landbloom, R
    RoyByrne, PP
    Tuason, VB
    Carman, JS
    Stokes, PE
    Williams, R
    Ancill, RJ
    MacEwan, GW
    Gujavarty, KS
    Jones, B
    Lohr, JB
    [J]. NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) : 111 - 123
  • [3] BORISON RL, 1992, PSYCHOPHARMACOL BULL, V28, P213
  • [4] BRECHER MB, 1997, 150 ANN M AM PSYCH A, P233
  • [5] RISPERIDONE IN THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA - A METAANALYSIS
    CARMAN, J
    PEUSKENS, J
    VANGENEUGDEN, A
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (04) : 207 - 213
  • [6] Casey DE, 1997, J CLIN PSYCHIAT, V58, P55
  • [7] CHOUINARD G, 1993, J CLIN PSYCHOPHARM, V13, P25
  • [8] CONLEY RR, 1999, ANN M AM COLL NEUR P
  • [9] Daniel DG, 1996, AM J PSYCHIAT, V153, P417
  • [10] ANTIDEPRESSANT ACTIVITY AND MANIA ASSOCIATED WITH RISPERIDONE TREATMENT OF SCHIZOAFFECTIVE DISORDER
    DWIGHT, MM
    KECK, PE
    STANTON, SP
    STRAKOWSKI, SM
    MCELROY, SL
    [J]. LANCET, 1994, 344 (8921) : 554 - 555